Emerging research indicates that 4FMA, a novel copyright compound, might hold exciting potential for therapeutic applications. While still in its developmental phase, studies have demonstrated that 4FMA can evoke vivid copyright experiences, potentially rivaling those of more conventional psychedelics like LSD and copyright. Scientists are current